TaiGen Biotechnology Co (太景生技) plans to seek regulatory approval for its new drug Taigexyn to be used in the treatment of diabetic ulcers as the company’s novel antibiotic starts sales in China.
The company expects sales of the new antibiotic in one of the world’s fastest-growing markets to bring in royalty income and provide an additional revenue stream, it said in a statement on Sunday.
Taigexyn — a non-fluorinated, broad-spectrum quinolone for the treatment of drug-resistant bacterial infections — has been approved for the treatment of community-acquired pneumonia by health regulators in Taiwan and China.
Commercialization of the new drug is limited, as the drug has only received approval for the treatment of a single indication via oral administration, the company said.
“Although Taigexyn is primarily marketed as a treatment for community-acquired pneumonia in China, drug prescriptions are determined by physicians and medical institutions,” a TaiGen investor relations official told the Taipei Times by telephone.
The official added that the company’s development efforts remain unhampered by regulatory limitations.
Regulatory policies are changing rapidly in China, and favorable turns might accelerate approval for additional indications, the official said.
The race to develop new treatments to fight superbugs — such as methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumonia — has been growing in importance across the world, in particular in developing nations, and regulators have given fast-track approval for antibiotics.
Taigexyn is the first new Class 1.1 drug developed by a Taiwanese company to receive market approval in China, while its approval in the US is being helped by incentives and fast-track designations under the country’s antibiotics reforms.
Sales of quinolones in China last year totaled an estimated 6.4 billion yuan (US$944.9 million), the company said, citing data from IMS Health Inc, a US-based healthcare industry information and services provider.
Market observers have said that Taigexyn could see annual sales in China peak at about 1 billion yuan.
Zhejiang Medicine Co (浙江醫藥), which partnered with TaiGen to market and manufacture Taigexyn, is expected to receive 7 percent to 11 percent of sales proceeds, TaiGen said.
TaiGen is also evaluating sales in developing markets such as India, where drug-resistant bacterial infections are more prevalent, the official said.
The company has also licensed Taigexyn to Russia’s R-Pharm and Mexico’s Productos Cientificos SA to tap into 30 Latin American, Central Asian and Eastern European markets.
TaiGen shares yesterday rose 3.63 percent to close at NT$30 in Taipei trading, bucking a 0.16 percent decline on the Taipei Exchange, the local bourse for firms with small and medium-sized capitalizations, exchange data showed.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the